Thiazole-substituted aminopyrimidines as spleen tyrosine kinase inhibitors
US9499534B2 · kind B2 · utility
1Cited by
20References
14Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Apr 22, 2014 |
| Grant date | Nov 22, 2016 |
| Priority date | — |
| Expiry date | Apr 22, 2034 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D417/12
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention provides certain thiazole-substituted aminopyrimidine compounds of the Formula (I) (I), or pharmaceutically acceptable salts thereof, wherein R1, R2, R3, R5, R6, and the subscripts r, s, and t are as defined herein. The invention also provides pharmaceutical compositions comprising such compounds, and methods of using the compounds for treating diseases or conditions mediated by Spleen Tyrosine Kinase (Syk).
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.